NO175883C - Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse - Google Patents

Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse

Info

Publication number
NO175883C
NO175883C NO885172A NO885172A NO175883C NO 175883 C NO175883 C NO 175883C NO 885172 A NO885172 A NO 885172A NO 885172 A NO885172 A NO 885172A NO 175883 C NO175883 C NO 175883C
Authority
NO
Norway
Prior art keywords
preparing
formulations
topical application
aqueous gel
gel formulation
Prior art date
Application number
NO885172A
Other languages
English (en)
Norwegian (no)
Other versions
NO885172D0 (no
NO175883B (no
NO885172L (no
Inventor
Robert John Borgman
Original Assignee
Galderma Sa
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175883(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Sa, Curatek Pharmaceuticals filed Critical Galderma Sa
Publication of NO885172D0 publication Critical patent/NO885172D0/no
Publication of NO885172L publication Critical patent/NO885172L/no
Publication of NO175883B publication Critical patent/NO175883B/no
Publication of NO175883C publication Critical patent/NO175883C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
NO885172A 1987-03-20 1988-11-18 Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse NO175883C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000584 WO1988006888A1 (en) 1987-03-20 1987-03-20 Novel topical metronidazole formulations and therapeutic uses thereof

Publications (4)

Publication Number Publication Date
NO885172D0 NO885172D0 (no) 1988-11-18
NO885172L NO885172L (no) 1988-11-18
NO175883B NO175883B (no) 1994-09-19
NO175883C true NO175883C (no) 1994-12-28

Family

ID=22202320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885172A NO175883C (no) 1987-03-20 1988-11-18 Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse

Country Status (10)

Country Link
EP (1) EP0305380B1 (de)
JP (1) JPH0825878B2 (de)
KR (1) KR950003919B1 (de)
AT (1) ATE67667T1 (de)
AU (1) AU610495B2 (de)
DE (1) DE3773383D1 (de)
DK (1) DK173844B1 (de)
FI (1) FI88582C (de)
NO (1) NO175883C (de)
WO (1) WO1988006888A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4859694A (en) * 1988-02-10 1989-08-22 Pavlich Frederick M Method for treating hoof thrush and hoof rot
GB8910076D0 (en) 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
GB9415290D0 (en) 1994-07-28 1994-09-21 Zeneca Ltd Gel formation
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
LT2544532T (lt) 2010-03-12 2017-06-12 Monsanto Technology Llc Agrocheminių gelių kompozicijos
EP2725904B1 (de) 2011-06-28 2024-12-11 Chemo Research SL Hochdosierte wässrige und mukoadhäsive metronidazol-gelformulierungen und ihre verwendung zur behandlung von bakterieller vaginose
EP3013368A1 (de) 2013-06-25 2016-05-04 Mission Pharmacal Company Neuartige formulierungen zur behandlung von vaginalen erkrankungen
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
EP4157206A1 (de) 2020-06-01 2023-04-05 The Procter & Gamble Company Verfahren zur verbesserung der penetration einer vitamin-b3-verbindung in die haut
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JPWO2022269665A1 (de) * 2021-06-21 2022-12-29
CN115350144A (zh) * 2022-07-28 2022-11-18 苏州弘森药业股份有限公司 一种甲硝唑水凝胶及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883661A (en) * 1971-11-09 1975-05-13 Syntex Inc Acne treatment
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment

Also Published As

Publication number Publication date
EP0305380A4 (de) 1989-06-26
EP0305380A1 (de) 1989-03-08
AU7233787A (en) 1988-10-10
JPH0825878B2 (ja) 1996-03-13
FI88582C (fi) 1993-06-10
KR950003919B1 (ko) 1995-04-20
FI885377A0 (fi) 1988-11-18
WO1988006888A1 (en) 1988-09-22
DK645488A (da) 1989-01-19
FI885377L (fi) 1988-11-18
FI88582B (fi) 1993-02-26
DE3773383D1 (de) 1991-10-31
NO885172D0 (no) 1988-11-18
EP0305380B1 (de) 1991-09-25
AU610495B2 (en) 1991-05-23
KR890701113A (ko) 1989-12-19
NO175883B (no) 1994-09-19
NO885172L (no) 1988-11-18
DK645488D0 (da) 1988-11-18
DK173844B1 (da) 2001-12-10
JPH01503061A (ja) 1989-10-19
ATE67667T1 (de) 1991-10-15

Similar Documents

Publication Publication Date Title
NO175883C (no) Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse
DE68914365D1 (de) Topische metronidazol-formulationen und deren verwendung als arzneimittel.
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
KR890007736A (ko) 11,28-디옥사-4-아자트리시클로[22.3.1.0^4·9]옥타코스-18-엔 유도체 및 이들을 함유한 약학적 조성물의 사용방법
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
DE3687341D1 (de) Hautwirksame pharmaka mit liposomen als wirkstofftraeger.
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
NO843240L (no) Indomethacinholdig gel-salve
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
FI862609A0 (fi) Akne motverkande produkt.
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
KR930012013A (ko) 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
DE3762018D1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
DK0727996T3 (da) Fendazolformuleringer
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
DE69433490D1 (de) Die herstellung und verwendungen von niedermolekularen agaren und agaroiden
EP0274104A3 (de) 13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut
US4915973A (en) Method for treating skin diseases
FI861329L (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
EA199900998A1 (ru) Полутвердый фармацевтический препарат, содержащий декскетопрофентрометамол
US5004599A (en) Method of treating nails
US6214889B1 (en) Topical application of formate for relief of adverse skin condition for humans